REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotoscana Farma S.A. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Support Activities for Transportation | Warehousing and Storage
Full name: Biotoscana Farma S.A. Profile Updated: October 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biotoscana Colombia currently consists of four units of products: Biological Essential Medicines Brand Name (MEM), and Pharmaceuticals Hospital, with the constant goal of providing safety and efficacy in the management of different pathologies. Its purpose is the purchase, sale, distribution, import, export and trade in the type of goods and parapharmaceutical.

Headquarters
Avenida Carrera 45 108 27 Torre 3 Oficina 1901
Bogota D.C.; Bogota D.C; Postal Code: 1014

Contact Details: Purchase the Biotoscana Farma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Biotoscana Farma S.A. report to view the information.
Outstanding Shares:
Purchase the Biotoscana Farma S.A. report to view the information.
Registered Capital:
Purchase the Biotoscana Farma S.A. report to view the information.
Incorporation Date:
January 13, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Biotoscana Farma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
7.88%
Total operating revenue
9.39%
Operating profit (EBIT)
28.41%
EBITDA
13.96%
Net Profit (Loss) for the Period
-16.89%
Total assets
4.26%
Total equity
11.18%
Operating Profit Margin (ROS)
1.21%
Net Profit Margin
-0.97%
Return on Equity (ROE)
-3.28%
Debt to Equity Ratio
-19.23%
Quick Ratio
-0.02%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?